Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autophagy and autoimmunity crosstalks.
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.
Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Glutathione in multiple sclerosis: More than just an antioxidant?
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
The utility of the Six-Spot Step Test as a measure of walking performance in ambulatory individuals with Multiple Sclerosis across the disability spectrum.
Role of Immune Cells in the Course of Central Nervous System Injury: Modulation with Natural Products.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Opexa Therapeutics Announces Tcelna™ as New Brand Name for MS Therapy
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Combined use of pharmacophoric models together with drug metabolism and genotoxicity "in silico" studies in the hit finding process.
Elan provides update post restructuring announcement of Tysabri collaboration
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Effects of Bacille Calmette-GuÉrin after the first demyelinating event in the CNS.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
282
283
284
285
286
287
288
289
290
…
next ›
last »